Search results
Moderna Drug Candidate Tapped for FDA Rare-Disease Pilot Program
Morningstar· 11 hours agoBy Colin Kellaher Moderna's mRNA-3705 drug candidate for a rare, genetic disorder of the liver has been chosen for a Food and Drug Administration pilot program aimed at addressing ...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 3 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program - Moderna...
Benzinga· 9 hours agoThursday, the FDA selected Moderna Inc’s MRNA mRNA-3705 for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) pilot program. “Selection for this ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 3 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Is Moderna Stock a Buy Now That It's a 2-Product Company? | The Motley Fool
The Motley Fool· 4 days agoThe shortened trading week that ended on May 31 was a strange one for the vaccine developer Moderna...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 6 days agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WPTZ Burlington· 6 hours agoThe Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 6 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 6 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...